116 related articles for article (PubMed ID: 8449029)
1. Treatment of autoimmune uveoretinitis in the rat with rapamycin, an inhibitor of lymphocyte growth factor signal transduction.
Roberge FG; Xu D; Chan CC; de Smet MD; Nussenblatt RB; Chen H
Curr Eye Res; 1993 Feb; 12(2):197-203. PubMed ID: 8449029
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of rapamycin and cyclosporin A in the treatment of experimental autoimmune uveoretinitis.
Martin DF; DeBarge LR; Nussenblatt RB; Chan CC; Roberge FG
J Immunol; 1995 Jan; 154(2):922-7. PubMed ID: 7814893
[TBL] [Abstract][Full Text] [Related]
3. Effects of FTY720, a novel immunosuppressant, on experimental autoimmune uveoretinitis in rats.
Kurose S; Ikeda E; Tokiwa M; Hikita N; Mochizuki M
Exp Eye Res; 2000 Jan; 70(1):7-15. PubMed ID: 10644416
[TBL] [Abstract][Full Text] [Related]
4. Treatment of experimental autoimmune uveoretinitis with atorvastatin and lovastatin.
Kohno H; Sakai T; Saito S; Okano K; Kitahara K
Exp Eye Res; 2007 Mar; 84(3):569-76. PubMed ID: 17208229
[TBL] [Abstract][Full Text] [Related]
5. Antigen-specific suppressor cells induced by FK506 in experimental autoimmune uveoretinitis in the rat.
Kawashima H; Fujino Y; Mochizuki M
Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2500-7. PubMed ID: 1702408
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive effects of polynactins (tetranactin, trinactin and dinactin) on experimental autoimmune uveoretinitis in rats.
Tanouchi Y; Shichi H
Jpn J Ophthalmol; 1987; 31(2):218-29. PubMed ID: 3499534
[TBL] [Abstract][Full Text] [Related]
7. Effects of a new immunosuppressive agent, FK506, on experimental autoimmune uveoretinitis in rats.
Kawashima H; Fujino Y; Mochizuki M
Invest Ophthalmol Vis Sci; 1988 Aug; 29(8):1265-71. PubMed ID: 2458329
[TBL] [Abstract][Full Text] [Related]
8. Effects of cyclosporine and other immunosuppressive drugs on experimental autoimmune uveoretinitis in rats.
Mochizuki M; Nussenblatt RB; Kuwabara T; Gery I
Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):226-32. PubMed ID: 3871750
[TBL] [Abstract][Full Text] [Related]
9. T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat.
Caspi RR; Roberge FG; McAllister CG; el-Saied M; Kuwabara T; Gery I; Hanna E; Nussenblatt RB
J Immunol; 1986 Feb; 136(3):928-33. PubMed ID: 2416842
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
[TBL] [Abstract][Full Text] [Related]
11. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
Egwuagu CE; Mahdi RM; Nussenblatt RB; Gery I; Caspi RR
J Immunol; 1993 Aug; 151(3):1627-36. PubMed ID: 8393049
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen.
Nussenblatt RB; Caspi RR; Mahdi R; Chan CC; Roberge F; Lider O; Weiner HL
J Immunol; 1990 Mar; 144(5):1689-95. PubMed ID: 2137841
[TBL] [Abstract][Full Text] [Related]
13. The suppressive effect of triptolide on experimental autoimmune uveoretinitis by down-regulating Th1-type response.
Wu Y; Wang Y; Zhong C; Li Y; Li X; Sun B
Int Immunopharmacol; 2003 Oct; 3(10-11):1457-65. PubMed ID: 12946442
[TBL] [Abstract][Full Text] [Related]
14. [Experimental autoimmune uveitis and retinitis induced by S-antigen immunization].
Misiuk-Hojło M; Ruiz-Moreno J; Thillaye B; de Kozak Y
Klin Oczna; 1993; 95(3-4):101-4. PubMed ID: 8377430
[TBL] [Abstract][Full Text] [Related]
15. T-lymphocyte and experimental autoimmune uveoretinitis.
Mochizuki M
Jpn J Ophthalmol; 1987; 31(2):230-4. PubMed ID: 3312733
[TBL] [Abstract][Full Text] [Related]
16. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.
Wildner G; Thurau SR
Eur J Immunol; 1995 May; 25(5):1292-7. PubMed ID: 7774632
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of intravitreal administration of tresperimus, an immunosuppressive drug, on experimental autoimmune uveoretinitis.
Bousquet E; Camelo S; Leroux les Jardins G; Goldenberg B; Naud MC; Besson-Lescure B; Lebreton L; Annat J; Behar-Cohen F; de Kozak Y
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5414-23. PubMed ID: 21666239
[TBL] [Abstract][Full Text] [Related]
18. Peripheral expression of rod photoreceptor arrestin induces an epitope-specific, protective response against experimental autoimmune uveoretinitis.
McPherson SW; Roberts JP; Gregerson DS
Curr Eye Res; 2005 Jun; 30(6):491-502. PubMed ID: 16020282
[TBL] [Abstract][Full Text] [Related]
19. Precipitation of experimental autoallergic uveoretinitis by cyclosporin A withdrawal: an experimental model of uveitis relapse.
Atkinson EG; Dinning WJ; Kasp E; Graham EM; Dumonde DC
Clin Exp Immunol; 1989 Oct; 78(1):108-14. PubMed ID: 2805414
[TBL] [Abstract][Full Text] [Related]
20. Experimental autoimmune uveoretinitis (EAU) in rats: isolation of S-antigen, EAU susceptibility of rat strains, genetic control of EAU induction, and effects of cyclophosphamide and irradiation on EAU.
Suzuki I; Takahashi S; Fujii Y; Fuyama S; Arai S
Jpn J Ophthalmol; 1989; 33(1):13-26. PubMed ID: 2659859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
